CEO and Chairman of BioStem Technologies (OTC: BSEM) has been honored as 2025 Florida Entrepreneur of The Year® Winner by Ernst & Young – a prestigious recognition that could propel BSEM to national and global stages while elevating patience care and setting new standards in MedTech excellence.
The future belongs to regenerative medicine, and BioStem Technologies (OTC: BSEM) is emerging as a trailblazer driving innovation, rapid revenue growth, and groundbreaking advancements. This expanding MedTech company utilizes the unique healing properties of perinatal tissue to develop, produce, and bring to market allografts designed for regenerative therapies in advanced wound care.
At the heart of BSEM’s approach is its proprietary BioREtain® processing technology, enabling the creation of life-changing products that deliver meaningful patient outcomes. Several positive news announcements are reflecting the tremendous growth potential of BSEM. This includes recently announcing record preliminary net revenue of $72.5 million for Q1 2025. This is a 73% increase compared to $41.9 million in Q1 2024. The company also ended the quarter with cash on hand at $26.7 million, an increase from $22.8 million on December 31st, 2024.
This was the strongest first quarter in the company’s history! On the capital markets front, BSEM remains in active review with the SEC regarding its Form 10 registration and uplisting process, and it looks forward to completing this milestone and becoming listed on Nasdaq. Being listed on the NASDAQ would open up the stock to new investors, especially on the institutional front!
Not long ago Jason Matuszewski, CEO and Chairman of the Board of BSEM was named an Entrepreneur Of The Year 2025 Florida Award winner! Winning the Entrepreneur of The Year® Florida Award highlights the company’s leadership, showcasing his ability to steer BSEM with vision and purpose.
For investors, this signals that the company is led by a proven, respected entrepreneur who has been independently vetted for driving meaningful growth and innovation—an important indicator of the company’s potential for long-term success.
Matuszewski now advances to the national Entrepreneur of The Year® competition this fall, with a chance to represent the U.S. on the global stage in 2026. As he moves forward, the company will benefit from ongoing exposure through Ernst & Young’s network, events, and media. Combined with BSEM’s existing product pipeline and potential FDA-related milestones. This creates a powerful narrative that may help sustain momentum, both fundamentally and in the stock price. This award is not just an honor—it’s a strategic asset that validates BSEM’s mission, leadership, and investment case at a critical stage in the company’s growth trajectory.
17(b) Disclosure: This message is a paid advertisement for BioStem Technologies (OTC: BSEM). The Street Sheet investor awareness services, including newsletters, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in The Street Sheet publications or presentations, including web content subject to change. The Street Sheet and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. The Street Sheet is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information contained herein is not intended to be used as the basis for investment decisions and should not be construed as advice intended to meet the particular investment needs of any investor. The information contained herein is not a representation or warranty and is not an offer or solicitation of an offer to buy or sell any security. To the fullest extent of the law Tag The Flag LLC dba The Street Sheet our specialists, advisors, and partners will not be liable to any person or entity for the quality, accuracy, completeness, reliability or timeliness of the information provided, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information provided to any person or entity (including but not limited to lost profits, loss of opportunities, trading losses and damages that may result from any inaccuracy or incompleteness of this information). Stock market investing is inherently risky. Tag The Flag LLC dba The Street Sheet is not responsible for any gains or losses that result from the opinions expressed in newsletters, publications or presentations, including web content that it publishes electronically or in print. We strongly encourage all viewers to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov/or the Ontario Securities Commission (“OSC”) at www.osc.gov.on.ca. BioStem Technologies (OTC: BSEM) is a client of Sideways Frequency who has contracted Tag The Flag LLC dba The Street Sheet. Through Sideways Frequency, BioStem Technologies (OTC: BSEM) agreed to pay Tag The Flag LLC dba The Street Sheet a one-time $2,000 in exchange for this advertisement, sent to its subscribers. Programs provided to subscribers and Companies by Tag The Flag LLC dba The Street Sheet are designed to help small-cap companies communicate their investment characteristics. Tag The Flag LLC dba The Street Sheet investor awareness services include newsletters, publications or presentations, including web content.
